Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

Cadastre-se

LH Labcorp Holdings Inc

231,06

0,00 (0,00%)

Pré-mercado

Última atualização: 07:59:16

Atrasado em 15 minutos

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

12/02/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Adam Gehring, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Glenn A. Eisenberg

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

Labcorp (NYSE:LH)
Gráfico Histórico do Ativo
De Nov 2024 até Dez 2024

Click aqui para mais gráficos Labcorp.

Labcorp (NYSE:LH)
Gráfico Histórico do Ativo
De Dez 2023 até Dez 2024

Click aqui para mais gráficos Labcorp.

Notícias Labcorp Holdings Inc

Labcorp Launches H5 Bird Flu Test in the U.S., Now Available for Order through Physicians
Terça, 17 de Dezembro de 2024 (1 semana atrás) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Quarta, 4 de Dezembro de 2024 (3 semanas atrás) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Quarta, 4 de Dezembro de 2024 (3 semanas atrás) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Quarta, 4 de Dezembro de 2024 (3 semanas atrás) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Terça, 3 de Dezembro de 2024 (3 semanas atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Segunda, 2 de Dezembro de 2024 (4 semanas atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Segunda, 2 de Dezembro de 2024 (4 semanas atrás) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Terça, 26 de Novembro de 2024 (1 mês atrás) • Edgar (US Regulatory)

Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients
Terça, 26 de Novembro de 2024 (1 mês atrás) • PR Newswire (US)

Outcomes4Me and Labcorp Study Reveals Digital Education Can Increase HER2-low Awareness for Metastatic Breast Cancer Patients
Terça, 26 de Novembro de 2024 (1 mês atrás) • PR Newswire (US)

Form 4 - Statement of changes in beneficial ownership of securities
Segunda, 25 de Novembro de 2024 (1 mês atrás) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Sexta, 22 de Novembro de 2024 (1 mês atrás) • Edgar (US Regulatory)

Mais Notícias de Labcorp Holdings Inc

Índice Bovespa

Grupo Casas Bahia ON

Fictor Alimentos ON

Aeris Industria E Comerc... ON

MAGAZINE LUIZA ON

Brava Energia ON

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições